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Abstract
Covalent modifications of histones play crucial roles in chromatin structure and genomic stability. Recently, we reported a novel
modification of histones: biotinylation of lysine residues. Here we provide evidence that K12-biotinylated histone H4 (K12Bio H4) maps
specifically to both heterochromatin (alpha satellite repeats in pericentromeric regions) and transcriptionally repressed chromatin (g-G globin
and interleukin-2) in human lymphoblastoma cells. The abundance of K12Bio H4 in these regions was similar to that of K9-dimethylated
histone H3, a known marker for heterochromatin. Likewise, K8-biotinylated histone H4 (K8Bio H4) mapped to heterochromatin, but the
relative enrichment was smaller compared with K12Bio H4. Stimulation of interleukin-2 transcriptional activity with phorbol-12-myristate-
13-acetate and phytohemagglutinin caused a rapid depletion of K12Bio H4 in the gene promoter. These data are consistent with a novel role
for biotin in chromatin structure and transcriptional activity of genes.
D 2007 Elsevier Inc. All rights reserved.
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1. Introduction
DNA-binding proteins such as histones H1, H2A, H2B,
H3 and H4 play crucial roles in the regulation of chromatin
structure and maintenance of genomic stability. Nucleoso-
mal core particles in eukaryotes are composed of 147 base
pairs (bp) of DNA wrapped around an octamer of core
histones, consisting of two H2A-H2B dimers and one H3-
H3-H4-H4 tetramer; linker histone H1 associates with the
DNA connecting two core particles [1]. N-terminal tails of
histones are exposed at the nucleosomal surface and are
targets for a multitude of covalent modifications such as
acetylation and methylation of lysine residues and phos-
phorylation of serine residues [2,3]. These modifications
form the basis for epigenetic events such as those regulating
the transcriptional activity of genes and DNA repair
processes. For example, K9-dimethylated histone H3
(K9Me2 H3) is associated with heterochromatin such as in
major and minor satellite repeats in pericentromeric regions,
and transposons in humans and mice [4,5], whereas K4-
trimethylated histone H3 (K4Me3 H3) is associated with
promoter regions in euchromatic genes [6,7]. Methylation of
CpG islands in gene promoters is another epigenetic event
mediating gene silencing and usually colocalizes with
K9Me2 H3 in chromatin [4].
We recently identified a novel modification of histones
by using mass spectrometry, synthetic peptides and bio-
tinylation site-specific antibodies: binding of the vitamin
biotin to E-amino groups in lysine residues [8]. Specifically,
the following biotinylation sites have been identified: K9,
K13, K125, K127 and K129 in histone H2A [9], K4, K9
and K18 in histone H3 [10] and K8 and K12 in histone H4
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[8]. The existence of biotinylated histones in human cells
has been confirmed by mass spectrometry [11]. Biotinyla-
tion of histones is catalyzed by biotinidase [12] and
holocarboxylase synthetase (HCS) [13] in two apparently
independent reactions. The biological functions of most
biotinylation sites are unknown. Preliminary evidence has
been provided that biotinylation of K8 and K12 in histone
H4 might play roles in the cellular response to double-strand
breaks in DNA and chromosome condensation during the M
phase of the human cell cycle [14–16]. More importantly,
biotinylated core histones appear to be associated with
transcriptionally silent chromatin in chicken erythrocytes
[17]. Here, we provide evidence that K12-biotinylated
histone H4 (K12Bio H4) and, perhaps, K8-biotinylated
histone H4 (K8Bio H4) are markers for heterochromatin in
pericentromeric regions and transcriptionally repressed
chromatin in human lymphoblastoma (Jurkat) cells.
2. Materials and methods
2.1. Cell culture
Jurkat cells (clone E6-1) and JAr choriocarcinoma cells
were obtained from ATCC (Manassas, VA). Cells were
cultured in humidified atmosphere (378C, 5% CO2) as
described [18]. Jurkat cells express interleukin-2 rapidly in
response to appropriate stimulation [18,19]. Here, in some
experiments cells were stimulated with 50 Ag/L of phorbol-
12-myristate-13-acetate (PMA) and 2 mg/L of phytohemag-
glutinin (PHA) for 2 h to change the status of the
interleukin-2 gene from transcriptionally repressed chroma-
tin to transcriptionally active chromatin.
Biotinylation of histones is mediated by HCS [13]. Here,
we generated HCS-deficient Jurkat cells by using small
interfering RNA (siRNA) and the pSilencer 4.1-CMV neo
vector (Ambion, Austin, TX); negative controls included
siRNA targeting glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) and a hairpin with limited homology to
sequences in the human genome. Jurkat cells were trans-
fected with the various pSilencer 4.1-CMV neo vectors, and
stably transformed cells were selected using 0.3 g/L G418
for 10 days. Knockdown of HCS messenger RNA (mRNA)
was confirmed by using real-time polymerase chain reaction
(PCR) as described below; abundance of HCS protein was
quantified by Western blot analysis using an antibody
described previously [9]. Here, HCS-deficient cells were
used as a control in chromatin immunoprecipitation (ChIP)
assays; a detailed account of genotypes and phenotypes
associated with holocarboxylase deficiency will be pre-
sented in a separate article.
2.2. Chromatin immunoprecipitation assay
ChIP assays were conducted as described [20] with minor
modifications. Briefly, Jurkat cells were cross-linked with
0.27 mol/L formaldehyde at room temperature for 15 min
when cross-linking was quenched by using 0.125 mol/L
glycine. Cells were collected by centrifugation and resus-
pended in lysis buffer (5 mmol/L PIPES, pH 8.0, 85 mmol/L
KCl, 0.5% NP40) with protease inhibitors; cells were
incubated at 48C for 10 min with vortexing. Nuclei were
collected by centrifugation and resuspended in nuclei buffer
(50 mmol/L Tris, pH 8.1, 10 mmol/L EDTA, 35 mmol/L
SDS). Samples were chilled on ice and DNAwas sheared by
using a Branson Sonifier (three 30-s pulses on ice at 60%
amplitude with 60 s in between pulses) to produce
fragments of approximately 1000 bp. Samples were
centrifuged and the chromatin solution was precleared by
using Immobilized Protein A on Trisacryl GF-2000 (Pierce;
Rockford, IL) at 48C for 2 hours. Aliquots were used for
generating input DNA (without antibody precipitation) and
for immunoprecipitation with antibodies at 48C overnight.
The following antibodies were used for ChIP assays. The
Table 1
Specificity of monoclonal antibody to K8Bio H4
Probe Target peptide
K8Bio
[CKGGK(Bio)GLGKGGA]
K12Bio
[CKGGKGLGK(bio)GGA]
Optical density (450 nm)
Anti-K8Bio 3.4F0.6 0.8F0.1
PBS/Tween 0.1F0.01 0.1F0.02
Preimmune
serum
0.1F0.03 0.1F0.03
Microtiter wells were coated with K8- and K12-biotinylated peptides based
on human histone H4. Peptides were probed using monoclonal antibody to
K8Bio H4 by ELISA. Negative controls were generated by probing
peptides with phosphate-buffered saline (PBS) containing 0.05% Tween
and preimmune serum.
Fig. 1. Specificity and cellular localization of monoclonal antibody to
K8Bio H4. (A) Monoclonal antibody to K8Bio H4 binds does not cross-
react with recombinant, nonbiotinylated histone H4 (Lane 1) but binds to
biotinylated histone H4 in an extract of bulk histones from Jurkat cells
(Lane 2). (B) Monoclonal antibody to K8Bio H4 localizes to the nucleus in
JAr chroriocarcinoma cells. The nuclear compartment was stained with
DAPI, histones were stained using anti-K8Bio H4, and the cytoplasm was
stained by using rhodamine phalloidin. The image entitled bMergedQ was
created by overlaying images obtained by staining with DAPI, antibody and
rhodamine phalloidin.
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polyclonal antiserum against K12Bio H4 has been charac-
terized before [8]. This antiserum is highly specific for
K12Bio H4 [8]; titration experiments suggested that this
antiserum has an affinity for K12Bio H4 that is at least
45 times greater than the affinity for K8Bio H4. The anti-
serum against K8Bio H4 is also very specific for biotiny-
lated histone H4 (as opposed to other classes of histones and
nonbiotinylated histones), but shows some cross-reactivity
with K12Bio H4 [8]; specifically, the antiserum against
K8Bio H4 has an approximately three times greater affinity
for a synthetic peptide based on K8Bio H4 than for a
peptide based on K12Bio H4. In select experiments we used
a monoclonal antibody to K8Bio H4 (see below) to confirm
findings made by using the polyclonal antibody to K8Bio
H4; these samples were incubated with a goat anti-mouse
secondary antibody (Sigma, St. Louis, MO) for 1 h subse-
quent to incubation with the monoclonal antibody. Affinity-
purified antibodies against K9Me2 H3 and K4Me3 H3 were
purchased from Abcam (Cambridge, MA). Protein A-puri-
fied rabbit IgG against K12Ac H4 was purchased from
Upstate (Lake Placid, NY). Affinity-purified rabbit IgG to
the C-terminus in histone H4 was purchased from Abcam
(cat. no. ab10158). Chromatin was precipitated for 2 h using
Immobilized Protein A Trisacryl GF-2000. Cross-linking
was reversed by using 200 mmol/L sodium chloride (658C
overnight), and RNA was removed by using RNase A
(10 g/L). Finally, protein was digested with Proteinase K
(558C, 2 h) and DNA was purified by using the QIAprep
Spin Miniprep Kit (Qiagen, Valencia, CA). Each immuno-
precipitation was repeated three times.
2.3. Monoclonal antibodies
A monoclonal antibody to K8Bio H4 was generated in
the monoclonal antibody facility at the University of
Nebraska Medical Center (Omaha, NE) by using routine
procedures [21]. The antibody facility is approved by the
Institutional Animal Care and Use Committee and the U.S.
Department of Agriculture. No procedures causing pain to
the animal were performed without the use of appropriate
anesthesia and subsequent analgesia. For injection into mice
we purchased a K8-biotinylated peptide based on amino
acids 5 through 15 in histone H4 (University of Virginia
Biomolecular Research Facility, Charlottesville, VA); the
peptide contained an additional N-terminal cysteine for
conjugation to keyhole limpet hemocyanin (Pierce) before
injection: CKGGK(biotin)GLGKGGA. In addition, a K12-
biotinylated peptide [CKGGKGLGK(biotin)GGA] was
obtained for specificity testing by enzyme-linked immuno-
sorbent assay (ELISA) described below. Peptide identities
and purities were confirmed by using mass spectrometry
and high-performance liquid chromatography. K8-biotiny-
lated peptide was injected into mice, and hybridoma cells
secreting antibody specific for K8Bio H4 were identified by
ELISA (see below). IgG rather than IgM accounted for anti-
K8Bio H4, as judged by Western blot analysis using a
secondary Fc-specific antibody against IgG (data not
shown). IgG secreted by hybridoma cells was purified
using affinity chromatography. Briefly, bovine IgG intro-
duced by fetal bovine serum (culture media) was removed
by using a goat anti-bovine IgG column. Mouse IgG in the
flow-through was purified by using a protein G column; IgG
was eluted with 100 mmol/L glycine, pH 2.7. IgG was
stabilized by adjusting the concentrations of Tris and NaCl
to 40 and 150 mmol/L, respectively (pH 7.0).
The specificity of monoclonal anti-K8Bio H4 for distinct
biotinylation sites was tested by ELISA. Briefly, K8-
biotinylated and K12-biotinylated peptides were conjugated
to bovine serum albumin by using Imject Activated BSA
Table 2
PCR primers used for quantification of DNA from ChIP experiments (denoted bChIPQ) and transcripts (denoted bTransQ)
Target Experiment Size (bp) Forward primers Reverse primers
Locationa Sequence Location Sequence
ADH5 ChIP and Trans 146 +606 5V-GCATAATTGAGCCTACGCC-3V +732 5V-GCAGAGGTGTTTGTTACGTG-3V
Chr1alpha ChIPb and Trans 136 N/A 5V-TCATTCCCACAAACTGCGTTG-3V N/A 5V-TCCAACGAAGGCCACAAGA-3V
Chr4alpha ChIP and Trans 139 N/A 5V-CTGCACTACCTGAAGAGGAC-3V N/A 5V-GATGGTTCAACACTCTTACA-3V
GAPDH ChIP 293 +1399 5V-CCCAACTTTCCCGCCTCTC-3V +1692 5V-CAGCCGCCTGGTTCAACTG-3V
GAPDH Trans 323 +28 5V-ACCACAGTCCATGCCATCAC-3V +350 5V-GAGACCACCTGGTGCTCAG-3V
g-G glob ChIP and Trans 195 +84 5V-TCTACCCATGGACCCAGAGGT-3V +278 5V-CCACATGCAGCTTGTCACAGT-3V
HCS Trans 101 +1 5V-ATGGAAGATAGACTCCACAT-3V +102 5V-TGAGACCTGATCCTTAACTTCC-3V
IL-2prom ChIP 350 459 5V-CCACCCCCTTAAAGAAAGGA-3V 109 5V-ATTGTGGCAGGAGTTGAGGT-3V
IL-2, 5V end ChIP 257 +29 5V-TGCAACTCCTGTCTTGCATT-3V +286 5V-GAATCCCAAACTCACCAGGA-3V
IL-2, 3V end ChIP 232 +6340 5V-AACCCAGATTACCTCAAGGTGGCA-3V +6570 5V-AGTCCCAGCAGGAAATAGATGGCA-3V
IL-2prom2 ChIPc 286 387 5V-GAGCTATCACCTAAGTGTGGGCTAA-3V 101 5V-TGTGGCAGGAGTTGAGGTTACTGT-3V
IL-2 Trans 390 +29 5V-TGCAACTCCTGTCTTGCATT-3V +419 5V-ATGGTTGCTGTCTCATCAGC-3V
ADH5=aldehyde dehydrogenase 5 (GenBank AY987960); Chr1alpha=chromosome 1 alpha satellite repeats (GenBank M26919); Chr4alpha=chromosome 4
alpha satellite repeats (GenBank M38467); g-G glob=gamma-G globin (GenBank X55656); GAPDH=glyceraldehyde-3-phosphate dehydrogenase (GenBank
AY340484 for ChIP; GenBank BC013852 for RT-PCR); HCS=holocarboxylase synthetase (GenBank NM_000411); IL-2prom and IL-2prom2= interleukin-2
promoter (GenBank AJ006884); IL-2, 5V end=5V end of the interleukin-2 gene (GenBank X00695); IL-2, 3V end=3V end of the interleukin-2 gene (GenBank
AF359939); IL-2, interleukin-2 (GenBank BC066257); N/A=not applicable.
a Relative to transcription start site (=+1).
b These primers were used for both semiquantitative and real-time PCR.
c These primers were used only for real-time PCR.
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(Pierce) according to the manufacturer’s instructions. Micro-
titer plates were coated with albumin-conjugated peptides,
and unspecific adsorption sites were blocked by using a
buffer containing 0.1 mol/L HEPES (pH 7.0), 1 mol/L NaCl,
0.01% (wt/vol) bovine serum albumin and 0.05% (vol/vol)
Tween 20 [22]. Antibody binding was quantified following
routine ELISA procedures, using 0.66 Ag of anti-K8Bio H4
per well. Binding of monoclonal antibody was quantified by
using goat anti-mouse IgG (Fc specific) peroxidase conjugate
(Sigma; 28 Ag/L final concentration) and 3,3V,5,5V-tetrame-
thylbenzidine (bSureblue microwell peroxidase substrate,Q
KPL, Gaithersburg, MD). Blanks were prepared by using
mouse preimmune serum and IgG-free buffers. ELISA data
are consistent with the notion that the monoclonal antibody
specifically targets K8Bio H4 (Table 1).
Antibody specificities were further tested by Western blot
analysis as described [8]. Recombinant (nonbiotinylated)
histone H4 (Upstate) was probed with monoclonal anti-
K8Bio H4 (8 Ag/L final concentration) to determine whether
the antibody cross-reacts with nonbiotinylated histone H4.
Histone extracts from Jurkat cells contain biotinylated
histones H1, H2A, H2B, H3 and H4 in similar quantities
[23]; extracts were probed with monoclonal anti-K8Bio H4
to identify potential cross-reactivity with histones H1, H2A,
H2B and H3. In all Western blot experiments, goat anti-
mouse IgG peroxidase conjugate (Sigma) was used as
secondary antibody at a final concentration of 70 Ag/L.
Western blot analysis is consistent with the notion that
monoclonal anti-K8Bio H4 does not cross-react with
nonbiotinylated histone H4 and biotinylated histones H1,
H2A, H2B and H3, but specifically binds to biotinylated
histone H4 (Fig. 1A).
Effectiveness of antibodies in ChIP assays was tested by
using Western blot analysis. Chromatin was precipitated by
using polyclonal anti-K12Bio H4 as described above for
ChIP assays; cross-linking with formaldehyde and digestion
with protease were omitted. Proteins were resolved by gel
electrophoresis as described [8] and transblots were probed
by using the above antibody to the C-terminus in histone H4
(0.5 mg/L final concentration). Mouse monoclonal anti-
rabbit IgG peroxidase conjugate (Sigma) was used as
secondary antibody. Controls included transblots probed
without primary antibody (negative control) and bulk
extracts of Jurkat cell histones probed with the antibody to
the C-terminus in histone H4 (positive control).
Finally, immunocytochemistry was used to determine
whether monoclonal anti-K8Bio H4 colocalizes with bio-
tinylated histones in the cell nucleus. Immunocytochemistry
experiments were conducted in JAr human choriocarcinoma
cells as described [9]. Primary antibody was used at a
concentration of 3.3 mg/L. As secondary antibody we used
Cy2-conjugated donkey anti-mouse IgG (Jackson Immu-
noResearch Laboratories, West Grove, PA; 16 Ag/L final
concentration). Cytoplasmic and nuclear compartments
were stained with rhodamine phalloidin and 4V,6-diami-
dino-2-phenylindole (DAPI), respectively, as described [24].
Images were obtained by using an Olympus FV500
confocal microscope (Microscopy Core Facility, University
of Nebraska, Lincoln, NE). Immunocytochemistry data are
consistent with the notion that monoclonal anti-K8Bio H4
colocalized with nuclear histones (Fig. 1B).
2.4. Semiquantitative PCR
Semiquantitative PCR was conducted as described [25]
using the primers provided in Table 2 [26]. For hot-start
PCR, we used Platinum TAQ DNA polymerase (Invitrogen,
Carlsbad, CA) and equal amounts (micrograms) of immu-
noprecipitated DNA and input DNA. The reactions were run
at 958C for 10 min, followed by 40 cycles of 958C for 30 s,
with annealing for 30 s and extension at 728C for 30 s.
Ethidium-bromide-stained bands were quantified by gel
densitometry. Only values from the exponential phase of
PCR amplification (typically 19–30 cycles) were included in
Fig. 2. Relative enrichment of heterochromatin by ChIP assay in Jurkat cells.
Chromatin was immunoprecipitated using antibodies to K12Bio H4, K8Bio
H4, K9Me2 H3 and K4Me3 H3. DNA was amplified by semiquantitative
PCR, using primers specific for alpha satellite repeats on chromosomes 1 (A)
and 4 (B); only values from within the exponential phase of amplification
were considered for quantitative analysis. Bar graphs depict the relative
enrichment of precipitated DNA compared with input DNA (meanFS.D.,
n =3). a,b,c,dBars not sharing the same letter are significantly different
( P b.05). Gels depict representative examples from PCR.
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data analysis. Gel densitometry data from ChIP experiments
represent three independent PCR reactions each conducted
using DNA from independent immunoprecipitations. Note
that it can be misleading to compare relative enrichments
between ChIP experiments with different antibodies, which
might have distinct efficiencies in ChIP assays.
We used reverse transcriptase PCR to confirm that
transcription of heterochromatin was quantitatively minor
compared with euchromatin. Transcripts from genes and
alpha satellite repeats were detected as described [25], using
the primers (denoted bTransQ) provided in Table 2.
Theoretically, contamination of RNA with genomic DNA
might produce false-positive results in PCR experiments.
For the interleukin-2 gene, this possibility was formally
excluded by the size of the anticipated PCR product: 4655
bp if genomic DNA was the template vs. 390 bp if
complementary DNA was the template. For all other PCR
reactions, we included controls in which genomic DNAwas
removed by treating RNA extracts with RNase-free DNase
in combination with RNeasy spin columns (Qiagen).
2.5. Real-time PCR
For select genomic loci (alpha satellite repeats in
chromosome 1, interleukin-2 promoter) we confirmed the
relative enrichment in immunoprecipitated DNA by using
real-time PCR (iCycler IQ multicolor real-time detection
system; Bio-Rad, Palo Alto, CA). For amplification of alpha
satellite sequences we used the same primers that were used
for semiquantitative PCR; for interleukin-2 promoter
sequences we used a pair of primers distinct from that used
for semiquantitative PCR (Table 2). Moreover, the abun-
dance of mRNA coding for HCS in siRNA-treated cells was
quantified by real-time PCR. ABsolute QPCR SYBR Green
fluorescein mix (ABgene, Rochester, NY) was used for real-
time PCR reactions.
2.6. Statistical analysis
Homogeneity of variances among groups was confirmed
by using Bartlett’s test [27]. Significance of differences
among groups was tested by one-way ANOVA. Fisher’s
Protected Least Significant Difference procedure was used
for post hoc testing [27]. StatView 5.0.1 (SAS Institute,
Cary, NC) was used to perform all calculations. Differences
were considered significant if Pb.05. Data are expressed as
meanFS.D.
3. Results and discussion
Jurkat cell chromatin was precipitated by using anti-
bodies against K12Bio H4, K8Bio H4, K9Me2 H3 and
K4Me3 H3. In a first series of ChIP assays, the purified
DNAwas amplified by semiquantitative PCR, using primers
specific for pericentromeric alpha satellite repeats in
chromosomes 1 and 4 (Table 2). Precipitation of chromatin
by using anti-K12Bio H4 produced a 1.9-fold enrichment of
alpha satellite repeats from chromosomes 1 and 4, respec-
tively, compared with input DNA (Fig. 2 and Table 3). The
fold enrichment by anti-K12Bio H4 was very similar to the
Table 3
Relative enrichment of heterochromatin, transcriptionally repressed chro-
matin and euchromatin by ChIP assay in Jurkat cells
PCR target Chromatin Antibody
for ChIP
Relative
enrichment
by ChIP
Chr1alpha Heterochromatin K12Bio H4 1.9F0.06a
K8Bio H4 1.4F0.2b
K9Me2 H3 1.8F0.1a
K4Me3 H3 1.0F0.05c
Chr4alpha Heterochromatin K12bio H4 1.9F0.1a
K8Bio H4 1.2F0.06b
K9Me2 H3 2.1F0.1c
K4Me3 H3 0.8F0.06d
g-G globin Repressed
chromatin
K12Bio H4 1.3F0.06a
K8Bio H4 0.9F0.08b
K9Me2 H3 1.3F0.08a
K4Me3 H3 0.7F0.06c
IL-2
(unstimulated)
Repressed
chromatin
K12Bio H4 1.4F0.06a
K8Bio H4 1.0F0.06b
K9Me2 H3 1.5F0.1a
K4Me3 H3 1.0F0.1b
IL-2 (stimulated) Active chromatin K12Bio H4 0.7F0.06a
K8Bio H4 1.0F0.05b
K9Me2 H3 0.8F0.1a
K4Me3 H3 1.5F0.02c
ADH5 Euchromatin K12Bio H4 0.9F0.1a
K8Bio H4 1.0F0.05a
K9Me2 H3 0.9F0.1a
K4Me3 H3 2.0F0.05b
GAPDH Euchromatin K12Bio H4 1.1F0.1a
K8Bio H4 1.4F0.1b
K9Me2 H3 1.1F0.05a
K4Me3 H3 2.2F0.2c
Chromatin was immunoprecipitated by using antibodies to K12Bio H4,
K8Bio H4, K9Me2 H3 and K4Me3 H3. DNA was amplified by
semiquantitative PCR for 19 to 30 cycles; only values from within the
exponential phase of amplification were considered for quantitative
analysis. Values represent the relative enrichment of precipitated DNA
compared with 0.1% of input DNA (meanFS.D., n =3). Enrichment of
interleukin-2 was quantified with and without stimulation of gene
expression, using 50 Ag/L of PMA and 2 mg/L of PHA for 2 h.
ADH5=aldehyde dehydrogenase 5; Chr1alpha=chromosome 1 alpha
satellite repeats; Chr4alpha=chromosome 4 alpha satellite repeats; IL-
2= interleukin-2. a,b,c,dRows not sharing the same letter are significantly
different for a given PCR target ( P b.05).
Fig. 3. The antibody to K12Bio H4 is effective in immunoprecipitations.
Chromatin from Jurkat cells was immunoprecipitated by using antibody to
K12Bio H4, and proteins were resolved by gel electrophoresis. Transblots
were probed with an antibody to the C-terminus in histone H4 (Lane 1) or
in the absence of primary antibody (Lane 2). Bulk histone extracts from
Jurkat cells were probed with the antibody to the C-terminus in histone H4
and served as positive control (Lane 3).
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1.8- to 2.1-fold enrichment observed for the known
heterochromatin mark K9Me2 H3, suggesting that K12Bio
H4 is associated with heterochromatin. In contrast, ChIP
with an antibody to the euchromatin marker K4Me3 H3 was
not associated with enrichment of alpha satellite repeats.
Finally, precipitation of chromatin by using anti-K8Bio H4
produced a 1.2- and 1.4-fold enrichment of alpha satellite
repeats from chromosomes 1 and 4, respectively, compared
with input DNA. This level of enrichment is intermediate
relative to that observed for anti-K9Me2 H3 (marker for
heterochromatin) and anti-K4Me3 H3 (marker for euchro-
matin). More importantly, the levels of enrichment observed
here are similar to levels reported in previous studies in
humans and mice [5–7]. Collectively, these observations are
consistent with the notion that K12Bio H4 and, perhaps,
K8Bio H4 play roles in heterochromatic structures.
We conducted the following experiments to demonstrate
that the above observations were specific for K8Bio H4 and
K12Bio H4. First, chromatin was precipitated with bulk
rabbit IgG; no enrichment of alpha satellite repeats was
observed in these experiments (data not shown). Second,
chromatin was immunoprecipitated with anti-K12Bio H4
and proteins were resolved by gel electrophoresis. Immu-
noprecipitation specifically enriched for histone H4, as
judged by probing with an antibody to the C-terminus in
histone H4 (Fig. 3, Lane 1). No bands were detectable if
transblots were probed with secondary antibody in the
absence of primary antibody (Lane 2). Bulk extracts of
Jurkat cell histones served as positive control and produced
a strong signal (Lane 3). Third, HCS-deficient Jurkat cells
were generated by using siRNA. The abundance of mRNA
coding for HCS decreased by 70.5F6.6% in siRNA-treated
cells compared with wild-type controls (Fig. 4A); in
contrast, the abundance of mRNA coding for GAPDH
Fig. 4. Expression of HCS decreases in response to transformation of Jurkat
cells with HCS-specific siRNA. Expression of HCS was quantified by real-
time PCR (A) and Western blot analysis (B) in cells treated with an empty
siRNA vector (denoted bWild-typeQ) and cells treated with an HCS-specific
vector (denoted bHCS-deficientQ). Values are meansFS.D. (*P b.05 vs.
wild-type controls, n =3).
Fig. 5. Relative enrichment of transcriptionally repressed chromatin by
ChIP assay in Jurkat cells. Chromatin was immunoprecipitated using
antibodies to K12Bio H4, K8Bio H4, K9Me2 H3 and K4Me3 H3. DNA
was amplified by semiquantitative PCR, using primers specific for the
promoter regions in genes coding for g-G globin (A) and interleukin-2 (B);
enrichment for interleukin-2 was also quantified after stimulation of
interleukin-2 expression with 50 Ag/L of PMA and 2 mg/L of PHA for 2
h (C). Only values from within the exponential phase of amplification were
considered for quantitative analysis. Bar graphs depict the relative
enrichment of precipitated DNA compared with input DNA (meanFS.D.,
n =3). a,b,cBars not sharing the same letter are significantly different
( P b.05). Gels depict representative examples from PCR.
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was not affected by knockdown of HCS, suggesting
specificity of treatment (data not shown). Decreased
abundance of HCS mRNA was associated with decreased
abundance of the corresponding protein (Fig. 4B), as judged
by gel densitometric analysis of Western blots (arbitrary
units): 7.2F0.3 units in wild-type cells vs. 1.2F0.1 units in
siRNA-treated cells (n=3; Pb.05). The control protein
histone H3 was not affected by transformation with the
siRNA vector (data not shown). The abundance of
biotinylated histones was substantially decreased in HCS-
deficient cells. For example, if chromatin from knockdown
cells was precipitated with anti-K12Bio H4, the amount of
DNA was only about 10% compared with wild-type
controls. Fourth, real-time PCR (as opposed to semiquan-
titative PCR) was used to quantify relative enrichment of
alpha satellite repeats in chromosome 1. Here, we used a
monoclonal antibody to K8Bio H4 to independently
confirm the observations made with the polyclonal antibody
to K8Bio H4 in the experiments above; in addition, we used
polyclonal anti-K12Bio H4 to quantify the relative enrich-
ment of repeat sequences by real-time PCR. Briefly, the
relative enrichment of alpha satellite repeats was 1.4F0.04
for K12Bio H4, 1.5F0.04 for K8Bio H4 and 1.4F0.05 for
K9Me2 H4 (Pb.05). These trends are similar to those
described above.
Biotinylated histones H4 were also associated with
transcriptionally repressed chromatin, following a pattern
similar to that observed for alpha satellite repeats. Immu-
noprecipitation of chromatin by using anti-K12Bio H4
caused a 1.3- and 1.4-fold enrichment of g-G globin and
interleukin-2 sequences, respectively, as judged by semi-
quantitative PCR (Fig. 5 and Table 3). The fold enrichment
by anti-K12Bio H4 was similar to the 1.3- to 2.1-fold
enrichment observed by using anti-K9Me2 H3, suggesting
that K12Bio H4 is not only associated with pericentromeric
repeats but also with transcriptionally repressed chromatin.
Enrichment of c-G globin and interleukin-2 sequences by
ChIP with anti-K8Bio H4 was weaker than that observed for
anti-K12Bio H4. The relative enrichments at the interleukin-
2 promoter locus were confirmed by real-time PCR. The
following enrichments were observed: 1.5F0.2 for K12Bio
H4, 1.7F0.2 for K9Me2Bio H3 and 1.2F0.1 for K4Me3Bio
H3 (Pb.05). These levels of enrichment are similar to those
calculated in experiments using semiquantitative PCR.
We used reverse transcriptase PCR to confirm that the
transcription of repressed chromatin (g-G globin and
interleukin-2) was quantitatively minor compared with
transcriptionally active chromatin (Fig. 6). Note that tran-
scripts of alpha satellite repeats were detectable by reverse
transcriptase PCR (Fig. 6), which is consistent with
previous observations [5]. In control experiments, RNA
was treated with DNase before reverse transcriptase PCR to
remove any genomic DNA. Treatment with DNase did not
decrease the signal intensity obtained by reverse transcrip-
tase PCR (data not shown), suggesting that PCR products
originated from RNA.
K12Bio H4 localized specifically to the transcriptional
start site of the interleukin-2 gene as opposed to localizing
Fig. 6. Abundance of transcripts in Jurkat cells. Transcripts from the
following regions in chromatin were amplified by RT-PCR: alpha satellite
repeats on chromosomes 1 and 4 (Lanes 1 and 2, respectively), g-G globin
(Lane 3), interleukin-2 in unstimulated cells (Lane 4), interleukin-2 in cells
stimulated with 50 Ag/L of PMA and 2 mg/L of PHA for 2 h (Lane 5),
aldehyde dehydrogenase 5 (Lane 6) and GAPDH (Lane 7). Samples were
amplified for 32 PCR cycles.
Fig. 7. Relative enrichment of euchromatin by ChIP assay in Jurkat cells.
Chromatin was immunoprecipitated by using antibodies to K12Bio H4,
K8Bio H4, K9Me2 H3 and K4Me3 H3. DNA was amplified by
semiquantitative PCR, using primers specific for aldehyde dehydrogenase
5 (A) and GAPDH (B); only values from within the exponential phase of
amplification were considered for quantitative analysis. Bar graphs depict
the relative enrichment of precipitated DNA compared with input DNA
(meanFS.D., n = 3). a,b,cBars not sharing the same letter are significantly
different ( P b.05). Gels depict representative examples from PCR.
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equally to the entire gene locus. Here, we quantified the
relative enrichment of sequences from the promoter region,
the 5V end and the 3V end of the interleukin-2 gene by using
anti-K12Bio H4 and semiquantitative PCR (see Table 2 for
PCR primers). Sequences from the promoter region of the
interleukin-2 gene were enriched 1.5F0.3-fold by immu-
noprecipitation with anti-K12Bio H4, confirming the data
from Fig. 5. Likewise, sequences from the 5V end region of
the interleukin-2 gene were enriched 1.4F0.1-fold by using
anti-K12Bio H4. In contrast, sequences from the 3V end of
the interleukin-2 gene were enriched only 0.9F0.4-fold by
using anti-K12Bio H4. Previous studies have suggested that
the majority of histone modifications involved in gene
regulation reside within 500 to +500 bp of the transcrip-
tion start site [6]. Collectively, these observations are
consistent with the notion that K12Bio H4 participates in
the regulation of transcriptional activity.
Next, we determined whether stimulation of interleukin-
2 expression by treatment with PMA and PHA was
associated with corresponding changes of histone biotiny-
lation at the interleukin-2 promoter. Interleukin-2 was
selected as a model because expression of this cytokine is
below the limit of detection in unstimulated lymphoid cells
and increases substantially in response to mitogenic
stimulation, as judged by using mRNA abundance, reporter
gene activity and secretion of interleukin-2 into culture
medium [28,29]. Here, we observed a substantial decrease
in the relative enrichment of interleukin-2 promoter
sequences in chromatin from stimulated Jurkat cells
precipitated with anti-K12Bio H4 compared with unstimu-
lated controls (Fig. 5, compare B and C, and Table 3):
enrichment decreased from about 1.4-fold in unstimulated
cells to 0.7-fold in stimulated cells. Likewise, enrichment
decreased by about 50% if chromatin from stimulated cells
was precipitated using anti-K9Me2 H3 compared with
unstimulated controls. Treatment with PMA and PHA did
not affect the relative enrichment of interleukin-2 promoter
sequences by anti-K8Bio H4. A potential explanation for
this absence of effect has been offered above. Also,
treatment with PMA and PHA did not affect the relative
enrichment of interleukin-2 promoter sequences by an
antibody to K12-acetylated histone H4 (K12Ac H4; data
not shown). K12ac H4 is a marker for transcriptionally
active chromatin [2,3]; it remains uncertain as to why
mitogenic stimulation of Jurkat cells was not associated
with increased K12 acetylation at the interleukin-2 locus in
this study. Treatment of Jurkat cells with PMA and PHA
was associated with a 50% increase in the enrichment of
interleukin-2 promoter sequences in cells precipitated with
anti-K4Me3 H3 (positive control). Reductions of K12Bio
H4 and K9Me3 H3 levels in response to gene activation
were apparently not caused by nucleosomal depletion at the
interleukin-2 locus. To independently verify changes in
nucleosomal abundance, we utilized antibodies to the
C-terminus of histone H4. This region of the H4 molecule
is not a known target for posttranslational modifications
[2,3] and an antibody to this portion of the H4 protein
should be expected to immunoprecipitate all chromatin
containing bound and accessible histone H4. When
chromatin was precipitated with such an antibody, no
differences in the relative abundance of interleukin-2
promoter sequences were observed between stimulated
cells compared with unstimulated controls (primer denoted
bIL-2promQ in Table 2; data not shown). These results, in
combination with the data obtained by using biotinylation-
specific antibodies, collectively suggest that biotinylated
histone H4 is not only associated with heterochromatin but
also with transcriptionally repressed chromatin. Moreover,
transcriptional activation of repressed chromatin genes
appears to be associated with a debiotinylation of K12Bio
H4 in the promoter regions of genes.
Consistent with the observations described above, anti-
bodies to K12Bio H4 and K8Bio H4 did not enrich for
aldehyde dehydrogenase 5 and GAPDH (Fig. 7 and Table 3).
Also, no enrichment of these sequences was observed if
chromatin was precipitated by using anti-K9Me2 H3. In
contrast, precipitation of chromatin by using anti-K4Me3
H3 was associated with a 2.0- and 2.2-fold enrichment of
promoter sequences from aldehyde dehydrogenase 5 and
GAPDH, respectively.
Collectively, the study presented here provides evidence
for a potential role of K12Bio H4 and, perhaps, K8Bio H4
in centromeric heterochromatin and silencing of euchroma-
tin. These findings are consistent with the following
observations, suggesting a role for biotinylation of histone
H4 in chromatin condensation. First, biotinylation of both
K8 and K12 in histone H4 increases during chromatin
condensation in the M phase of the human cell cycle [15].
Second, biotinylation of K12 in histone H4 decreases
transiently for about 30 min after occurrence of DNA
double-strand breaks, but returns to initial levels about 1 h
after induction of DNA breaks [14]. This is consistent with
chromatin decondensation immediately following DNA
breaks to give repair proteins access to sites of damage,
followed by condensation of chromatin to prevent dissoci-
ation of broken ends [30]. The observations reported here
have potentially far-reaching implications for biotin nutri-
tion in human health. For example, about one third of
pregnant women are marginally biotin deficient [31], with
the effects on gene silencing, cell proliferation and DNA
being unknown.
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